Abstract
Death rates from AIDS-related events in HIV-positive individuals have declined in the era of highly active antiretroviral therapy (HAART). It has also been shown that deaths from non-AIDS events have declined in this cohort since the advent of HAART. We review these data, as well as discussing some of the possible effects HAART might have on non-AIDS diagnoses and deaths in HIV-positive individuals with successfully treated HIV.
MeSH terms
-
Antiretroviral Therapy, Highly Active*
-
Cardiovascular Diseases* / diagnosis
-
Cardiovascular Diseases* / mortality
-
HIV Infections / complications*
-
HIV Infections / drug therapy*
-
HIV Infections / immunology
-
HIV-1
-
Humans
-
Kidney Failure, Chronic* / diagnosis
-
Kidney Failure, Chronic* / mortality
-
Liver Cirrhosis* / diagnosis
-
Liver Cirrhosis* / mortality
-
Neoplasms* / diagnosis
-
Neoplasms* / mortality
-
Randomized Controlled Trials as Topic